Relapse Rate in Major Depressive Disorder with Multiple Episodes
For adults with major depressive disorder who have experienced multiple prior episodes, the relapse rate within the first year approaches 70-90%, with the highest risk occurring in the first 8-12 weeks after achieving remission. 1
Risk Stratification by Episode History
The relapse/recurrence probability follows a clear escalating pattern based on episode history:
- After first episode: ~50% probability of recurrence
- After two episodes: ~70% probability of recurrence
- After three or more episodes: ~90% probability of recurrence 1
This progressive increase in risk is critical for clinical decision-making, as patients with multiple episodes represent a fundamentally different risk profile than those with a single episode.
Temporal Pattern of Relapse
The risk is not evenly distributed across the year. The greatest vulnerability occurs in the initial months after remission:
- The probability of remaining well is approximately 76% at 6 months and 63% at 1 year after recovery 2
- Peak risk occurs in the first 8-12 weeks after discontinuing treatment 3
- Risk then declines steadily but remains elevated throughout the first year 4
Clinical Context and Predictors
Beyond episode count, several factors significantly increase first-year relapse risk:
- Residual subthreshold symptoms at time of recovery (odds ratio 3.3) 5, 6
- Lack of partner/social support 7
- Premature discontinuation of antidepressants during the acute phase 1
The combination of multiple prior episodes plus residual symptoms creates approximately 3-fold increased risk compared to patients with neither factor 5.
Treatment Implications
Antidepressant medication does not prevent relapse if discontinued at the end of the acute phase 1. For patients with recurrent depression (defined as three or more episodes), clinical guidelines strongly recommend:
- Continuation of antidepressant therapy for at least 12 months after achieving remission 1, 8
- Consider prolonged or indefinite maintenance treatment given the 90% recurrence risk 1
- Monthly monitoring for 6-12 months after symptom resolution, extending to 2 years for recurrent episodes 3
Important Caveats
The 70-90% relapse rate applies specifically to patients with multiple prior episodes (typically defined as 2-3 or more). This is substantially higher than the ~50% rate seen after a first episode. Additionally, relapse rates may be higher in psychiatric specialty settings (approaching 61% in one study) compared to primary care, suggesting that severity and complexity of illness influence these rates 7.
The evidence consistently demonstrates that continued pharmacotherapy significantly reduces recurrence rates compared to placebo in patients with recurrent depression, though it does not appear to affect the trend toward increasing severity of subsequent episodes 2.